XML 102 R90.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT INFORMATION - Segment Revenues and Profit (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 08, 2021
May 26, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Segment reporting information            
Revenues     $ 2,100 $ 1,664 $ 4,127 $ 3,676
Operating (loss) income     (270) (27) (491) 221
Amortization of intangible assets     (360) (436) (717) (872)
Goodwill impairments     0 0 (469) 0
Asset impairments     (47) (1) (195) (15)
Restructuring, integration and separation costs     (9) (7) (21) (11)
Other expense, net     (542) (118) (512) (154)
Interest income     2 2 4 9
Interest expense     (364) (385) (732) (781)
Loss on extinguishment of debt $ (38) $ (27) (45) (27) (50) (51)
Foreign exchange and other     7 0 8 (13)
Loss before benefit from income taxes     (670) (437) (1,261) (615)
Bausch + Lomb            
Segment reporting information            
Revenues     934 677 1,815 1,552
Salix            
Segment reporting information            
Revenues     516 404 988 881
International Rx            
Segment reporting information            
Revenues     313 249 619 540
Ortho Dermatologics            
Segment reporting information            
Revenues     137 117 278 248
Diversified Products            
Segment reporting information            
Revenues     200 217 427 455
Operating Segment            
Segment reporting information            
Revenues     2,100 1,664 4,127 3,676
Operating (loss) income     887 680 1,803 1,574
Operating Segment | Bausch + Lomb            
Segment reporting information            
Revenues     934 677 1,815 1,552
Operating (loss) income     213 124 452 387
Operating Segment | Salix            
Segment reporting information            
Revenues     516 404 988 881
Operating (loss) income     370 289 697 608
Operating Segment | International Rx            
Segment reporting information            
Revenues     313 249 619 540
Operating (loss) income     103 75 212 173
Operating Segment | Ortho Dermatologics            
Segment reporting information            
Revenues     137 117 278 248
Operating (loss) income     61 38 131 85
Operating Segment | Diversified Products            
Segment reporting information            
Revenues     200 217 427 455
Operating (loss) income     140 154 311 321
Corporate            
Segment reporting information            
Operating (loss) income     $ (199) $ (145) $ (380) $ (301)